bioAffinity Technologies proudly will present at Advancing Early Lung Cancer Detection at the Cleveland Clinic, an invitation-only symposium that brings together clinical experts, advocacy groups and industry leaders working to advance new technologies and methods necessary to find lung cancer at its earliest stages.
September 26 and 27, 2019
Cleveland, Ohio
The Advancing Early Lung Cancer Detection Symposium is intended to accelerate the development and implementation of tools to assist with the early detection of lung cancer. This is the second Symposium, and bioAffinity’s second invitation to present before the nation’s top clinical experts and advocacy groups who are interested in innovations addressing a shared goal of finding lung cancer at its earliest stages when treatment is most effective.
